CD19 CAR T cell product and disease attributes predict leukemia remission durability. - Finney OC; Brakke HM; Rawlings-Rhea S; Hicks R; Doolittle D; Lopez M; Futrell RB; Orentas RJ; Li D; Gardner RA; Jensen MC (The Journal of clinical investigation, 2019)